|
SkyePharma soars on asthma drug approval
Telegraph.co.uk By Rachel Cooper, City Reporter SkyePharma has been hurt by concerns over its asthma therapy, Flutiform, with the share price taking a tumble just before Christmas as traders learnt of another delay to its European approval. SkyePharma asthma drug wins European backing SkyePharma's asthma drug wins European backing |
View full post on asthma – Google News